Alternatives to Mabylon

Developing engineered biologics to harness the immune system for disease treatment.

Developing novel therapeutics targeting dysfunctional DNA packaging for diseases like cancer.

Adimab is a biotechnology company that discovers and develops therapeutic antibodies using its proprietary yeast-based platform.

Biotechnology company developing novel immunotherapies for cancer.

Biopharmaceutical company developing antibody-based therapeutics for cancer and autoimmune diseases.

Clinical-stage biotechnology company developing allogeneic gamma delta T cell therapies for cancer and autoimmune diseases.

Biopharmaceutical company developing antibody therapeutics for cancer and autoimmune diseases.

Clinical-stage biotech developing AI-driven metabolic immunotherapies for cancer and autoimmune diseases.

Global biopharmaceutical company pioneering mRNA-based immunotherapies and vaccines for cancer and infectious diseases.

Develops novel therapeutic antibodies for oncology and autoimmune diseases.

Clinical-stage company developing novel oncology therapies to overcome tumor immune evasion and drug resistance.

Biopharmaceutical company developing therapies for neurodegenerative diseases, focusing on crossing the blood-brain barrier.

A global oncology company developing and commercializing innovative cancer treatments.

ImCheck Therapeutics is a clinical-stage immuno-oncology company developing novel antibody therapies.

Caris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.

Clinical-stage precision medicine company using protein motion insights for drug discovery.

Guardant Health is a precision oncology company that develops and commercializes liquid biopsy tests for cancer detection, recurrence monitoring, and treatment selection.

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

A clinical-stage oncology company developing DNA interference (DNAi) based cancer therapies.

Biotech company using AI and computational platforms to design novel peptide therapeutics.

Biotech company developing next-generation gene writing tools for advanced therapies.

Leap Therapeutics is a clinical-stage biopharmaceutical company focused on developing novel targeted and immuno-oncology therapies.

Biopharmaceutical company developing novel cancer therapies using targeted protein degradation.

AI platform for drug discovery and development, optimizing targets, compounds, and combination therapies.

Developing novel radiopharmaceuticals for targeted cancer treatment using advanced molecular imaging and therapy.

Alto Neuroscience is a clinical-stage biopharmaceutical company developing precision psychiatry medicines for mental health conditions.

Developing microbiome-derived therapies to overcome resistance to immune checkpoint inhibitors in cancer treatment.

AI-powered platform for antibody discovery and development to create new medicines.

Biopharmaceutical company developing mRNA-based vaccines and therapeutics for infectious diseases and cancer.

Developing human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.

Clinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases.

Clinical-stage biopharma developing precisely designed cancer therapeutics using a proprietary cell-free protein synthesis platform.

A clinical-stage genome editing company developing novel therapies using CRISPR/Cas9 technology for severe diseases.

SNIPR Biome is a clinical-stage company developing CRISPR-based therapeutics to precisely target and eliminate specific bacteria in the human microbiome.

A clinical-stage biopharmaceutical company developing novel immunotherapies.

A global biotechnology company discovering, developing, manufacturing, and delivering innovative human therapeutics.

A global contract research organization specializing in preclinical and translational oncology research.

Developing novel diagnostics to predict patient response to immunotherapy.

Developing Quantum ADCs against the tumor microenvironment for innovative cancer therapies.

Developing immunotherapeutic bi-functional fusion proteins to harness the immune system against cancer.

Narya Bio is developing novel therapeutic antibodies for challenging diseases.

Cradle Bio B.V. is a Dutch, Swiss biotechnology company that develops software using machine learning for protein engineering. It was founded in 2021 and is base

Immunotherapy company targeting oncology and autoimmune diseases.

Leveraging the adaptive immune system to diagnose and treat disease.

Clinical-stage immunotherapy company developing novel treatments for cancer.

South Korean biopharmaceutical company developing novel biologics for cancer and rare diseases.

Clinical-stage biopharmaceutical company developing novel boron-based small molecule therapeutics for rare infectious diseases and oncology.

Developing a next-generation, off-the-shelf, in vivo engineered monocyte immunotherapy platform for solid tumors.

A commercial-stage immunotherapy company developing novel treatments for cancer and infectious diseases.

AI-powered platform for understanding disease biology and accelerating drug discovery.

AI-guided drug discovery platform for tissue-targeted medicines.

Phenomics-driven AI company translating disease biology into precision medicine discoveries.

Biopharmaceutical company developing novel therapeutics for cancer and other diseases using chemoproteomics and covalent chemistry.

Synthace provides a no-code cloud platform for life sciences R&D, enabling scientists to automate experimentation and insight sharing.

Computational protein design company creating novel enzymes and proteins using AI and physics-based modeling.

AI-driven drug discovery platform for rapid development of novel therapeutics.

Mapping cell-cell communication at scale in human tissue.

AI-powered biotechnology company developing RNA therapeutics for genetic diseases.

Clinical-stage genetic medicine company developing AAV-mediated treatments for cardiovascular and Alzheimer's diseases.